Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SenesTech, Inc. - Common Stock (NQ:SNES)

4.000 +0.240 (+6.38%)
Streaming Delayed Price Updated: 2:25 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about SenesTech, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
SenesTech (SNES) Q2 Sales Jump 36%
Via The Motley Fool
Earnings Scheduled For August 7, 2025
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
Earnings Scheduled For November 12, 2024
 
Via Benzinga
Insights into SenesTech's Upcoming Earnings
 
Via Benzinga
(SNES) - Analyzing SenesTech's Short Interest
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
SenesTech's Big Play On Small Pests
Via Talk Markets
Topics Stocks / Equities
SenesTech CEO Reveals Surprise San Francisco Expansion
A discussion about the $4B rodent control market and the company’s game-changing product Evolve – a revolutionary form of rodent birth control. 
Via Talk Markets
Topics Stocks / Equities
SenesTech: A Little-Known Biotech Company Worthy Of Attention
SenesTech, an under-the-radar biotech company with a focus on solving the global pest population problem through, humane fertility control measures, seems attractively valued. 
Via Talk Markets
Topics Stocks / Equities
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
SenesTech CEO Interview: Breaking Down Record Earnings & The Road To Profitability
With no direct competition in the fertility control space and growing demand for non-lethal rodent management, could SNES be the next big winner? Find out in this deep-dive conversation with CEO Joel... 
Via Talk Markets
Topics Stocks / Equities
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
SenesTech's Financing Move: $1.1 Million From Warrant Exercise, New Deals Loom
SenesTech shares lower as they exercise outstanding warrants for 374,718 shares at reduced price, plans to use proceeds for corporate purposes. 
Via Benzinga
Earnings Scheduled For March 12, 2025
 
Via Benzinga
SenesTech: The Smart Money’s Bet On Rodent Population Control
SenesTech is a small company with an innovative way for rodent control using induced infertility. They have rapidly expanded with pilot programs in major US cities and also globally in New Zealand and... 
Via Talk Markets
Topics Stocks / Equities
SenesTech Has Built A Better Mouse Trap
SenesTech's Evolve products are recent, but take a novel approach to rodent plagues, painlessly reducing reproduction velocity and the product is already taking off with huge distribution deals in... 
Via Talk Markets
Topics Stocks / Equities
SenesTech Expands Rapidly With Evolve, Poised For Breakout Growth In 2025
SenesTech, a disruptive biotech firm, is quietly making major strides in municipal adoption, international expansion, and retail penetration. 
Via Talk Markets
Topics Stocks / Equities
SenesTech Expands Rapidly With Evolve, Poised For Breakout Growth In 2025
SenesTech is disrupting rodent control with Evolve, a fertility-based solution gaining traction in NYC & Baltimore. 
Via Talk Markets
Topics Stocks / Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
SNES Stock Earnings: SenesTech Beats EPS, Misses Revenue for Q2 2024
SNES stock results show that SenesTech beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
SNES Stock Earnings: SenesTech Misses EPS, Misses Revenue for Q1 2024
SNES stock results show that SenesTech missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.